Vertex Is Paying a 102% Premium to Acquire Crinetics for $10 Billion. Here's Whether the Deal Is Worth It.

In the latest big-ticket deal in the pharmaceutical industry, Vertex Pharmaceuticals (VRTX 2.50%) and Crinetics ...
IEEE Spectrum on MSN

Large tabular models excel where LLMs fail

Startup’s foundation model NEXUS tackles spreadsheets, AI’s surprising final frontier ...